Core Laboratories Inc.
CLB
$16.45
$0.342.11%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.63M | 31.19M | 22.11M | 19.16M | 21.47M |
| Total Receivables | 124.97M | 127.95M | 130.99M | 127.36M | 132.38M |
| Inventory | 58.24M | 59.77M | 59.03M | 59.40M | 65.49M |
| Prepaid Expenses | 10.06M | 10.52M | 10.31M | 10.18M | 9.72M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.01M | 8.25M | 6.34M | 10.52M | 6.17M |
| Total Current Assets | 226.91M | 237.68M | 228.77M | 226.61M | 235.23M |
|
|
|||||
| Total Current Assets | 226.91M | 237.68M | 228.77M | 226.61M | 235.23M |
| Net Property, Plant & Equipment | 152.01M | 153.04M | 155.43M | 153.55M | 154.26M |
| Long-term Investments | 100.01M | 100.00M | 99.45M | 99.45M | 99.45M |
| Goodwill | 100.01M | 100.00M | 99.45M | 99.45M | 99.45M |
| Total Other Intangibles | 6.11M | 6.17M | 6.28M | 6.40M | 6.55M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 106.32M | 105.23M | 101.59M | 99.32M | 104.99M |
| Total Assets | 591.36M | 602.11M | 591.52M | 590.41M | 600.47M |
|
|
|||||
| Total Accounts Payable | 36.95M | 41.70M | 38.50M | 34.55M | 33.63M |
| Total Accrued Expenses | 27.22M | 28.94M | 28.63M | 30.01M | 28.08M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.47M | 11.51M | 11.65M | 10.69M | 11.44M |
| Total Finance Division Other Current Liabilities | 20.11M | 22.62M | 24.95M | 22.34M | 21.80M |
| Total Other Current Liabilities | 20.11M | 22.62M | 24.95M | 22.34M | 21.80M |
| Total Current Liabilities | 95.74M | 104.77M | 103.73M | 97.59M | 94.94M |
|
|
|||||
| Total Current Liabilities | 95.74M | 104.77M | 103.73M | 97.59M | 94.94M |
| Long-Term Debt | 114.10M | 124.61M | 124.37M | 126.11M | 139.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 41.53M | 42.42M | 43.98M | 43.34M | 43.73M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 62.60M | 63.00M | 60.09M | 65.63M | 65.51M |
| Total Liabilities | 313.97M | 334.81M | 332.16M | 332.67M | 344.05M |
|
|
|||||
| Common Stock & APIC | 114.34M | 113.23M | 114.04M | 110.02M | 113.08M |
| Retained Earnings | 173.60M | 159.82M | 149.66M | 150.28M | 143.35M |
| Treasury Stock & Other | -16.60M | -11.77M | -10.31M | -8.31M | -5.68M |
| Total Common Equity | 271.35M | 261.28M | 253.39M | 251.99M | 250.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 271.35M | 261.28M | 253.39M | 251.99M | 250.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 6.04M | 6.02M | 5.97M | 5.75M | 5.68M |
| Total Equity | 277.39M | 267.30M | 259.36M | 257.74M | 256.42M |
|
|
|||||